1. Home
  2. PODD vs GIB Comparison

PODD vs GIB Comparison

Compare PODD & GIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • GIB
  • Stock Information
  • Founded
  • PODD 2000
  • GIB 1976
  • Country
  • PODD United States
  • GIB Canada
  • Employees
  • PODD N/A
  • GIB N/A
  • Industry
  • PODD Medical/Dental Instruments
  • GIB Professional Services
  • Sector
  • PODD Health Care
  • GIB Consumer Discretionary
  • Exchange
  • PODD Nasdaq
  • GIB Nasdaq
  • Market Cap
  • PODD 23.8B
  • GIB 20.1B
  • IPO Year
  • PODD 2007
  • GIB N/A
  • Fundamental
  • Price
  • PODD $317.83
  • GIB $90.92
  • Analyst Decision
  • PODD Strong Buy
  • GIB Buy
  • Analyst Count
  • PODD 18
  • GIB 4
  • Target Price
  • PODD $337.06
  • GIB $148.25
  • AVG Volume (30 Days)
  • PODD 662.8K
  • GIB 327.5K
  • Earning Date
  • PODD 11-06-2025
  • GIB 11-05-2025
  • Dividend Yield
  • PODD N/A
  • GIB 0.47%
  • EPS Growth
  • PODD N/A
  • GIB 5.62
  • EPS
  • PODD 3.32
  • GIB 5.54
  • Revenue
  • PODD $2,359,500,000.00
  • GIB $11,408,228,844.00
  • Revenue This Year
  • PODD $29.13
  • GIB $11.53
  • Revenue Next Year
  • PODD $18.13
  • GIB $5.16
  • P/E Ratio
  • PODD $94.90
  • GIB $15.93
  • Revenue Growth
  • PODD 26.00
  • GIB 7.13
  • 52 Week Low
  • PODD $225.37
  • GIB $87.26
  • 52 Week High
  • PODD $353.50
  • GIB $122.79
  • Technical
  • Relative Strength Index (RSI)
  • PODD 40.26
  • GIB 42.22
  • Support Level
  • PODD $306.03
  • GIB $87.26
  • Resistance Level
  • PODD $315.44
  • GIB $91.90
  • Average True Range (ATR)
  • PODD 8.58
  • GIB 1.47
  • MACD
  • PODD -1.93
  • GIB 0.20
  • Stochastic Oscillator
  • PODD 45.94
  • GIB 47.02

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

About GIB CGI Inc.

CGI is a Canada-based IT-services provider with an embedded position in North America and Europe. The company generates more than CAD 14 billion in annual revenue, employs over 90,000 personnel, and operates across 400 offices in 40 countries. CGI offers a broad portfolio of services such as consulting, systems integration, application maintenance, and business process services. Its largest vertical market is government, which contributes more than a third of group revenue.

Share on Social Networks: